INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.

$4.86  -0.10 (-2.02%)
As of 12/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  
IPO date:  07/25/2017
Outstanding shares:  45,572,689
Average volume:  29,048
Market cap:   $226,040,537
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   55.24
PB ratio:   0.50
PS ratio:   3.44
Return on equity:   0.91%
Net income %:   1.86%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy